H. Takeshima, S. Nishimura, T. Matsumoto, H. Ishida, K. Kangawa et al., Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor, Nature, vol.339, issue.6224, pp.439-484, 1989.
DOI : 10.1038/339439a0

N. Monnier, N. Romero, J. Lerale, P. Landrieu, Y. Nivoche et al., Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor, Human Molecular Genetics, vol.10, issue.22, pp.2581-92, 2001.
DOI : 10.1093/hmg/10.22.2581

N. Monnier, N. Romero, J. Lerale, Y. Nivoche, D. Qi et al., An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor, Human Molecular Genetics, vol.9, issue.18, pp.2599-608, 2000.
DOI : 10.1093/hmg/9.18.2599

H. Jungbluth, C. Müller, B. Halliger-keller, M. Brockington, S. Brown et al., Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores, Neurology, vol.59, issue.2, pp.284-291, 2002.
DOI : 10.1212/WNL.59.2.284

M. Davis, E. Haan, H. Jungbluth, C. Sewry, K. North et al., Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene, Neuromuscular Disorders, vol.13, issue.2, pp.151-158, 2003.
DOI : 10.1016/S0960-8966(02)00218-3

N. Romero, N. Monnier, L. Viollet, A. Cortey, M. Chevallay et al., Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia, Brain, vol.126, issue.11, pp.2341-1349, 2003.
DOI : 10.1093/brain/awg244

URL : http://doi.org/10.1093/brain/awg244

H. Zhou, H. Jungbluth, C. Sewry, L. Feng, E. Bertini et al., Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies, Brain, vol.130, issue.8, pp.2024-2060, 2007.
DOI : 10.1093/brain/awm096

N. Clarke, L. Waddell, S. Cooper, M. Perry, R. Smith et al., Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion, Human Mutation, vol.31, issue.7, pp.1544-1550, 2010.
DOI : 10.1002/humu.21278

URL : https://hal.archives-ouvertes.fr/inserm-00588144

H. Jungbluth, H. Zhou, C. Sewry, S. Robb, S. Treves et al., Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene, Neuromuscular Disorders, vol.17, issue.4, pp.338-383, 2007.
DOI : 10.1016/j.nmd.2007.01.016

URL : https://hal.archives-ouvertes.fr/hal-00189980

C. Arcy, A. Bjorksten, E. Yiu, A. Bankier, R. Gillies et al., KING-DENBOROUGH SYNDROME CAUSED BY A NOVEL MUTATION IN THE RYANODINE RECEPTOR GENE, Neurology, vol.71, issue.10, pp.776-783, 2008.
DOI : 10.1212/01.wnl.0000324929.33780.2f

D. Cauwer, H. Heytens, L. Martin, and J. , Workshop report of the 89th ENMC International Workshop: Central Core Disease, 19th???20th January 2001, Hilversum, The Netherlands, Neuromuscular Disorders, vol.12, issue.6, pp.588-95, 2002.
DOI : 10.1016/S0960-8966(02)00002-0

C. Sewry, C. Müller, M. Davis, J. Dwyer, J. Dove et al., The spectrum of pathology in central core disease, Neuromuscular Disorders, vol.12, issue.10, pp.930-938, 2002.
DOI : 10.1016/S0960-8966(02)00135-9

N. Romero, M. Herasse, N. Monnier, J. Leroy, D. Fischer et al., Clinical and histopathological aspects of Central Core Diseases associated and non-associated with RYR1 locus, Acta Myologica, vol.24, pp.70-73, 2005.

A. Ferreiro, B. Estournet, D. Chateau, N. Romero, C. Laroche et al., Multi-minicore disease-searching for boundaries: Phenotype analysis of 38 cases, Annals of Neurology, vol.52, issue.5, pp.745-57, 2000.
DOI : 10.1002/1531-8249(200011)48:5<745::AID-ANA8>3.0.CO;2-F

C. Sewry, Pathological defects in congenital myopathies, Journal of Muscle Research and Cell Motility, vol.37, issue.2, pp.231-239, 2008.
DOI : 10.1007/s10974-008-9155-8

I. Sato, S. Wu, M. Ibarra, Y. Hayashi, H. Fujita et al., Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation, Neurology, vol.70, issue.2, pp.114-136, 2008.
DOI : 10.1212/01.wnl.0000269792.63927.86

A. Ferreiro, N. Monnier, N. Romero, J. Leroy, C. Bönnemann et al., A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene, Annals of Neurology, vol.276, issue.11, pp.750-759, 2002.
DOI : 10.1002/ana.10231

H. Jungbluth, H. Zhou, L. Hartley, B. Halliger-keller, S. Messina et al., Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene, Neurology, vol.65, issue.12, pp.1930-1935, 2005.
DOI : 10.1212/01.wnl.0000188870.37076.f2

N. Monnier, I. Marty, J. Faure, C. Astiglioni, C. Desnuelle et al., Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores, Human Mutation, vol.130, issue.5, pp.670-678, 2008.
DOI : 10.1002/humu.20696

URL : https://hal.archives-ouvertes.fr/inserm-00381934

A. Taratuto, M. Sacolitti, F. Lubieniecki, N. Monnier, N. Romero et al., Progressive muscle biopsies morphological changes in long-term follow-up of multiminicore disease related to

J. Laporte, L. Hu, C. Kretz, J. Mandel, P. Kioschis et al., A gene mutated in X???linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast, Nature Genetics, vol.269, issue.2, pp.175-82, 1996.
DOI : 10.1146/annurev.physiol.53.1.201

M. Bitoun, S. Maugenre, P. Jeannet, E. Lacène, X. Ferrer et al., Mutations in dynamin 2 cause dominant centronuclear myopathy, Mutations in dynamin 2 cause dominant Centronuclear Myopathy, pp.1207-1216, 2005.
DOI : 10.1083/jcb.100.1.35

URL : https://hal.archives-ouvertes.fr/hal-00187451

N. Romero, Centronuclear myopathies: A widening concept, Neuromuscular Disorders, vol.20, issue.4, pp.223-231, 2010.
DOI : 10.1016/j.nmd.2010.01.014

J. Bevilacqua, M. Bitoun, V. Biancalana, A. Oldfors, G. Stoltenburg et al., ???Necklace??? fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy, Acta Neuropathologica, vol.64, issue.3, pp.283-91, 2009.
DOI : 10.1007/s00401-008-0472-1

I. Marty, M. Robert, M. Villaz, D. Jongh, K. Lai et al., Biochemical evidence for a complex involving dihydropyridine receptor and ryanodine receptor in triad junctions of skeletal muscle., Proceedings of the National Academy of Sciences, vol.91, issue.6, pp.2270-2274, 1994.
DOI : 10.1073/pnas.91.6.2270

G. Du, B. Sandhu, V. Khanna, X. Guo, and D. Maclennan, Topology of the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum (RyR1), Proceedings of the National Academy of Sciences, vol.99, issue.26, pp.16725-16755, 2002.
DOI : 10.1073/pnas.012688999

H. Zhou, M. Brockington, H. Jungbluth, D. Monk, P. Stanier et al., Epigenetic Allele Silencing Unveils Recessive RYR1 Mutations in Core Myopathies, The American Journal of Human Genetics, vol.79, issue.5, pp.859-68, 2006.
DOI : 10.1086/508500

T. Kimura, S. Pace, L. Wei, N. Beard, R. Dirksen et al., A variably spliced region in the type 1 ryanodine receptor may participate in an inter-domain interaction, Biochemical Journal, vol.401, issue.1, pp.317-341, 2006.
DOI : 10.1042/BJ20060686

S. Levano, M. Vukcevic, M. Singer, A. Matter, S. Treves et al., Increasing the number of diagnostic mutations in malignant hyperthermia, Human Mutation, vol.79, issue.4, pp.590-598, 2009.
DOI : 10.1002/humu.20878

D. Schotland, Congenital myopathy with target fibres, Trans Am Neurol Assoc, vol.92, pp.107-118, 1967.

D. Schotland, AN ELECTRON MICROSCOPIC STUDY OF TARGET FIBERS, TARGET???LIKE FIBERS AND RELATED ABNORMALITIES IN HUMAN MUSCLE, Journal of Neuropathology and Experimental Neurology, vol.28, issue.2, pp.214-242, 1969.
DOI : 10.1097/00005072-196904000-00003

J. Bevilacqua, M. Bitoun, S. Maugenre, A. Oldfors, B. Eymard et al., G.P.8 11 Towards the identification of new morphological subtypes of congenital myopathy, Neuromuscular Disorders, vol.16, issue.9-10, pp.709-719, 2006.
DOI : 10.1016/j.nmd.2006.05.213

L. Al-qusairi, N. Weiss, A. Toussaint, C. Berbey, N. Messaddeq et al., T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase, Proceedings of the National Academy of Sciences, vol.106, issue.44, pp.18763-18771, 2009.
DOI : 10.1073/pnas.0900705106

K. Claeys, M. Fardeau, R. Schröder, T. Suominen, K. Tolksdorf et al., Electron microscopy in myofibrillar myopathies reveals clues to the mutated gene, Neuromuscular Disorders, vol.18, issue.8, pp.656-66, 2008.
DOI : 10.1016/j.nmd.2008.06.367

M. Fardeau, Congenital myopathies, Skeletal Muscle Pathology, pp.161-203, 1982.
DOI : 10.1016/0013-4694(85)90101-4

M. Fardeau and T. F. , Congenital myopathies, Electroencephalography and Clinical Neurophysiology, vol.61, issue.3, pp.1500-1524, 1994.
DOI : 10.1016/0013-4694(85)90101-4

H. Zhou, N. Yamaguchi, X. Xu, Y. Wang, C. Sewry et al., Characterization of recessive RYR1 mutations in core myopathies, Hum Mol Genet, vol.18, pp.2791-803, 2006.

N. Monnier, A. Ferreiro, I. Marty, A. Labare-vila, P. Mezin et al., homozygous splicing mutation causing a depletion of skeletal muscle RYR1 is associated with MmD congenital myopathy with ophthalmoplegia, Hum Mol Genet, vol.12, pp.1-8, 2003.

N. Monnier, A. Laquerrière, S. Marret, A. Goldenberg, I. Marty et al., First genomic rearrangement of the RYR1 gene associated with an atypical presentation of lethal neonatal hypotonia, Neuromuscular Disorders, vol.19, issue.10, pp.680-684, 2009.
DOI : 10.1016/j.nmd.2009.07.007

URL : https://hal.archives-ouvertes.fr/inserm-00516069